logo

Soleno Therapeutics Inc (SLNO)



Trade SLNO now with
  Date
  Headline
5/14/2018 8:07:48 AM Soleno Therapeutics Begins Phase III Clinical Trial Of DCCR In Prader-Willi Syndrome
4/2/2018 8:06:13 AM Soleno Therapeutics Q4 Net Loss $5.0 Mln Or $0.43/Shr Vs Loss Of $2.6 Mln Or $0.82/Shr Last Year
2/20/2018 8:08:15 AM Soleno Reports Successful End-of-Phase II Meeting With FDA For DCCR In Prader-Willi Syndrome